Joe Walsh: Trump Needs a Primary Challenge The case for

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks
398
Joe Walsh: Trump Needs a Primary Challenge
The case for a contender from the right.


Opinion

By Joe Walsh
Mr. Walsh is a former Republican member of Congress from Illinois.

Aug. 14, 2019

There’s a strong case for President Trump to face a Republican primary challenger. I know a thing or two about insurgencies. I entered Congress in 2011 as an insurgent Tea Party Republican. My goals were conservative and clear: restrain executive power and reduce the debt. Barack Obama was president then, and it was easy for us to rail against runaway spending and executive overreach.

Eight years later, Mr. Trump has increased the deficit more than $100 billion year over year — it’s now nearing $1 trillion — and we hear not a word of protest from my former Republican colleagues. He abuses the Constitution for his narcissistic trade war.

In private, most congressional Republicans oppose the trade war, but they don’t say anything publicly. But think about this: Mr. Trump’s tariffs are a tax increase on middle-class Americans and are devastating to our farmers. That’s not a smart electoral strategy.


It’s one of the many reasons Mr. Trump is ripe for a primary challenger. In fact, it would buck the historical trend if he didn’t have one. More often than not, unpopular presidents face primary challengers.

Since leaving Congress in 2013, I’ve been the host of my own conservative talk radio show several hours a day, five days a week. The only time a majority of my conservative audience has noticeably broken with the president is when he signed the omnibus spending bill in 2017 that ballooned the deficit.

Fiscal responsibility is an issue the American electorate cares about but that our elected officials disregard from the top down — including the Tea Party in the Trump era.

Fiscal matters are only part of it. At the most basic level, Mr. Trump is unfit for office. His lies are so numerous — from his absurd claim that tariffs are “paid for mostly by China, by the way, not by us,” to his prevarication about his crowd sizes, he can’t be trusted.

In Mr. Trump, I see the worst and ugliest iteration of views I expressed for the better part of a decade. To be sure, I’ve had my share of controversy. On more than one occasion, I questioned Mr. Obama’s truthfulness about his religion. At times, I expressed hate for my political opponents. We now see where this can lead. There’s no place in our politics for personal attacks like that, and I regret making them.

I didn’t vote for Mr. Trump in 2016 because I liked him. I voted for him because he wasn’t Hillary Clinton. Once he was elected, I gave him a fair hearing, and tried to give him the benefit of the doubt.

But I soon realized that I couldn’t support him because of the danger he poses to the country, especially the division he sows at every chance, culminating a few weeks ago in his ugly, racist attack on four minority congresswomen.

The fact is, Mr. Trump is a racial arsonist who encourages bigotry and xenophobia to rouse his base and advance his electoral prospects. In this, he inspires imitators.

Republicans should view Mr. Trump as the liability that he is: No matter his flag-hugging, or his military parades, he’s no patriot. In front of the world, he sides with Vladimir Putin over our own intelligence community. That’s dangerous.

He encouraged Russian interference in the 2016 election, and he refuses to take foreign threats seriously as we enter the 2020 election. That’s reckless. For three years, he has been at war with our federal law enforcement and intelligence agencies, as he embraces tyrants abroad and embarrasses our allies. That’s un-American.

And despite what his enablers claim, Mr. Trump isn’t a conservative. He’s reckless on fiscal issues; he’s incompetent on the border; he’s clueless on trade; he misunderstands executive power; and he subverts the rule of law. It’s his poor record that makes him most worthy of a primary challenge.

Mr. Trump has taken the legitimate differences that Americans have on policy and turned them into personal division. He’s caused me to change my tone and to reflect upon where I went over the line and to focus on policy differences moving forward.

We now have a president who retweets conspiracy theories implicating his political opponents in Jeffrey Epstein’s death. We now have a president who does his level best to avoid condemning white supremacy and white nationalism.


Yes, William Weld, the former Massachusetts governor, is challenging Mr. Trump from the center. But the president is more vulnerable to a challenge from the right. I’m on the right, and I’m hugely disappointed that challenge hasn’t yet materialized.

Mr. Trump’s most vulnerable against a challenger who’d make the case for strong borders — instead of warning of “invaders,” dragging us down, turning neighbor against neighbor. A majority of Americans want fixes to our most basic problems.

We need someone who could stand up, look the president in the eye and say: “Enough, sir. We’ve had enough of your indecency. We’ve had enough of your lies, your bullying, your cruelty, enough of your insults, your daily drama, your incitement, enough of the danger you place this country in every single day. We don’t want any of this anymore, and the country certainly can’t stand four more years of it.”

Joe Walsh, a former Illinois congressman, is a nationally syndicated conservative talk radio host.

https://www.nytimes.com/2019/08/14/opinion/jo...;smtyp=cur
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles